N/A
Completed N=40
Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy
Biliary Colic · cholecystitis
Source: ClinicalTrials.gov NCT03380572 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
May 2019
Primary outcomePrimary: Operative Time — 86.5; 31.5 minutes
Summary
The Senhance™ surgical robotic system, previously known as Telelap Alf-X (TransEnterix, Morrisville, NC, USA) has recently become available in the UK. It aims to provide the robotic benefits of greater accuracy, dexterity and control with similar operational costs to traditional laparoscopy.
Patients randomly received either a standard laparoscopic cholecystectomy or the Senhance assisted cholecystectomy based on scheduled surgery date. A prospectively maintained database of the first 20 patients undergoing cholecystectomy with the Senhance Surgical System was retrospectively interrogated and compared to a concurrently treated group of 20 laparoscopically treated patients during the same timeframe.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Operative Time |
86.5; 31.5 | — |
| SECONDARY Morbidity Data |
3; 5 | — |
Eligibility Criteria
Inclusion Criteria
ASA I or II Confirmed diagnosis of biliary colic or cholecystitis Normal LFTs
Exclusion Criteria
Patients unable tor unwilling to consent BMI >40
Data sourced from ClinicalTrials.gov (NCT03380572). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.